🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gerd Fätkenheuer

University of Cologne

ORCID: 0000-0002-5054-1871

Also affiliated with German Center for Infection Research, Centrum für Integrierte Onkologie, University Hospital Cologne

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.744Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1878
Top 27%
0.744DataRank
Top 27%22 citations

Lene Ryom, Bastian Neesgaard, Gilles Wandeler, Thérèse Staub, Martin Gisinger +68 more

Papers

Driven by 6 papers — median percentile 73. Top paper: “Remdesivir for the Treatment of Covid-19 — Final Report”.

Remdesivir for the Treatment of Covid-19 — Final Report

New England Journal of Medicine(2020)10.1056/nejmoa2007764
N/A
12.3DataRank · unranked
7738 citations

Kay M Tomashek, Lori E. Dodd, Aneesh K. Mehta, Barry S. Zingman, André C. Kalil +35 more

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1878
Top 27%
0.744DataRank
Top 27%22 citations

Lene Ryom, Bastian Neesgaard, Gilles Wandeler, Thérèse Staub, Martin Gisinger +68 more

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae198
N/A
0.439DataRank · unranked
13 citations

Kevin Rubenstein, Viviane Callier, Katy Shaw-Saliba, Adam Rupert, Robin Dewar +94 more

Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV

Scientific Reports(2023)10.1038/s41598-023-29739-x
N/A
0.241DataRank · unranked
4 citations

Sarah Samorodnitsky, Chris H. Wendt, Jason V. Baker, Gary Collins, Monica Kruk +95 more

Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody

Cell(2020)10.1016/j.cell.2020.01.010
N/A
0DataRank · unranked
159 citations

Henning Gruell, Morgan E. Abernathy, My-Kim Tran, Adam S. Dingens, Harry B. Gristick +20 more

Dynamics and durability of HIV-1 neutralization are determined by viral replication

Nature Medicine(2023)10.1038/s41591-023-02582-3
N/A
0DataRank · unranked
17 citations

Dae Sung Kim, Maike Schlotz, Christoph Kreer, Ralf Eggeling, Anna Hake +45 more